Heptares Therapeutics
James Smith has over 15 years of experience in accounting and finance roles. Currently serving as an Assistant Accountant at Nxera Pharma since August 2022, James previously worked as a Finance and Purchasing Assistant at EBI for a decade. Earlier in James's career, a position was held as an Accounts and Personal Assistant at Cellzome from March 2008 to July 2012. This extensive background demonstrates a strong foundation in financial management and support.
Heptares Therapeutics
Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, StabilisedReceptors), overcoming a major limiting factor to the development of new drugs targeting this group.